Literature DB >> 29334120

Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion.

Jianlan Gu1,2,3, Weihua Wang1, Shichen Miao1, Feng Chen1,2, Feng Wu2, Wen Hu1,2, Khalid Iqbal2, Cheng-Xin Gong1,2, Fei Liu1,2.   

Abstract

Transactive response DNA-binding protein of 43 kDa (TDP-43) regulates RNA processing, including alternative splicing of tau exon 10. Pathological TDP-43 is hyperphosphorylated. However, how do the protein phosphatase(s) (PP) regulate TDP-43 phosphorylation is unclear. Here, we found that both PP1 and PP2A were coimmunoprecipitated with TDP-43. Treatment with calyculin A, but not with okadaic acid, increased TDP-43 phosphorylation at Ser379, Ser403/404, and Ser409/410 in cultured cells. PP1α, PP1β, and PP1γ interacted with TDP-43. Overexpression of PP1α and PP1γ, but not PP1β, suppressed TDP-43 phosphorylation at Ser403/404 and Ser409/410 and TDP-43-induced tau exon 10 inclusion. These findings suggest that PP1α and PP1γ regulate TDP-43 phosphorylation and its function in tau exon 10 inclusion mainly through its phosphorylation at Ser403/404 and Ser409/410.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  TDP-43; alternative splicing; protein phosphatase 1; tau

Mesh:

Substances:

Year:  2018        PMID: 29334120     DOI: 10.1002/1873-3468.12976

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  Phenotypic Suppression of ALS/FTD-Associated Neurodegeneration Highlights Mechanisms of Dysfunction.

Authors:  Mathieu Bartoletti; Daryl A Bosco; Sandrine Da Cruz; Clotilde Lagier-Tourenne; Nicole Liachko; Sebastian Markmiller; Kristin M Webster; Kristi A Wharton
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

Review 2.  Friend or foe-Post-translational modifications as regulators of phase separation and RNP granule dynamics.

Authors:  Mario Hofweber; Dorothee Dormann
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

Review 3.  Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes.

Authors:  Katherine E Prater; Caitlin S Latimer; Suman Jayadev
Journal:  Glia       Date:  2021-09-24       Impact factor: 7.452

Review 4.  The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?

Authors:  Rudolf C Hergesheimer; Anna A Chami; Denis Reis de Assis; Patrick Vourc'h; Christian R Andres; Philippe Corcia; Débora Lanznaster; Hélène Blasco
Journal:  Brain       Date:  2019-05-01       Impact factor: 13.501

Review 5.  Structural Insights Into TDP-43 and Effects of Post-translational Modifications.

Authors:  Liberty François-Moutal; Samantha Perez-Miller; David D Scott; Victor G Miranda; Niloufar Mollasalehi; May Khanna
Journal:  Front Mol Neurosci       Date:  2019-12-17       Impact factor: 5.639

6.  TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients.

Authors:  Elena Rita Simula; Giannina Arru; Ignazio Roberto Zarbo; Paolo Solla; Leonardo A Sechi
Journal:  Viruses       Date:  2021-11-18       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.